by Elena Iemma | May 16, 2023 | Featured, News
EpiVax is celebrating 25 years of innovative immunoinformatics tool development. The company’s mission is to improve the safety and efficacy of vaccines and protein therapeutics, while working to improve human health everywhere. 1998 EpiVax Founded by Dr. Annie De...
by Riley Nolan | Jan 25, 2021 | Thinking Out Loud -Blog
Fluidity over Division I have a confession to make. I am transfixed by Kpop. Well, actually, just BTS. I hadn’t been paying attention, honestly, until Kpop fans upended a Trump campaign event in Tulsa. And one thing led to another and there they were. Who are...
by Annie De Groot | Dec 22, 2020 | Thinking Out Loud -Blog
2020 Hindsight and Paying it Forward It has been an upside down year during which time we’ve learned a lot about our ability to work from home and still carry out global collaborations. EpiVax embraces the positive changes that have occurred and celebrates the...
by Annie De Groot | Oct 22, 2020 | Featured, News
PROVIDENCE, RI, October 22, 2020 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) and CUBRC, Inc. (“CUBRC”) announced today that they have been awarded a two-year, $1.1 million contract from the Office of Generic Drugs (OGD) in the Center of Drug Evaluation and Research...
by Annie De Groot | Oct 2, 2020 | Thinking Out Loud -Blog
Generic PANDAmonium I have been hanging out with an old dog – eight year old Jack, during the COVID lockdown. If you are a dog during COVID-19, long walks, lots of snuggles on the couch during Zoom meetings, what’s not to like? Hence the theme of my latest...
by Annie De Groot | Sep 23, 2020
Addressing Immunogenicity of Observed and Theoretical Impurities for Peptide Abbreviated New Drug Applications
by Annie De Groot | Jun 28, 2019 | Events
7th Annual Cambridge Healthtech Institute’s Immuno-Oncology Summit Powering Next Generation Targeted Immunotherapies Monday, August 5th – Friday August 9th Westin Boston Waterfront 425 Summer Street Boston, MA 02210 UPDATE: EpiVax Oncology (EO) would like...
by Admin Epivax | Jul 18, 2016
Recent Publications MOST RECENT PUBLICATIONS & POSTERS In silico methods for immunogenicity risk assessment and human homology screening for therapeutic antibodies. mAbs. 2024 Neoadjuvant personalized cancer vaccines: the final frontier? Expert Review of Vaccines....
by Admin Epivax | Nov 16, 2009 | News
Read the article at projo.com Providence’s Jewelry District: Growth hotspot? 01:00 AM EST on Saturday, November 14, 2009 By Philip Marcelo Journal Staff Writer PROVIDENCE — U.S. Rep. David R. Obey, chairman of the House Appropriations Committee, toured four major...
